Table 3. Meta-analyses of CD209 -336A/G promoter polymorphism and risk of TB after omitting the studies.

Polymorphism	OR(95% CI)	Z	P OR	I 2 (%)	P heterogeneity	Effectmodel
G vs. Aa	1.05(0.96, 1.14)	1.12	0.26	17	0.28	F
GG vs. AAa	1.16(0.95, 1.42)	1.46	0.15	0	0.74	F
GG+AG vs. AAb	0.98(0.86, 1.11)	0.29	0.77	36	0.12	F
GG vs. AG+AAa	1.11(0.93, 1.32)	1.14	0.26	0	0.98	F

Abbreviations and definitions: TB, tuberculosis; CI, 95% confidence intervals; OR, odds ratio; P _{heterogeneity,} P value of Q test for heterogeneity; F, fixed-effect models.

^a CD209 -336A/G promoter polymorphism and risk of TB after excluding the two studies of Zhuang et al. and Vannberg FO(a) et al.

^b CD209 -336A/G promoter polymorphism and risk of TB after excluding the three studies of Zhuang et al., Vannberg FO(a) et al. and Barreiro LB et al.